Literature DB >> 8235736

Variation in hemodialysis patient compliance according to demographic characteristics.

S I Bame1, N Petersen, N P Wray.   

Abstract

Patient noncompliance with treatment regime undermines the effectiveness of medical care, resulting in an unpredictable progression of the primary disease and a greater likelihood of complications. Hemodialysis patients are well suited for studying noncompliance because their treatment is prolonged and intensive, and medical regimens are clear cut and easily determined with objective measures. Moreover, noncompliant behavior by these patients not only endangers their life in the long run, but also results in negative effects within a day or two. Despite severe consequences, noncompliance with their medical regimen is the norm for dialysis patients rather than the exception. A large-scale study of chronic, outpatient hemodialysis patients (N = 1230 patients, response rate = 96%) treated in a variety of facility types (N = 29 facilities) was conducted to investigate prevalence and associated demographic characteristics of noncompliance with four treatment regimens--protein and potassium restrictions in the diet, medication regimen, and fluid restrictions. Few patients were noncompliant with diet regimens (9% with protein and 2% with potassium restrictions) but half were noncompliant with medication taking (50.2%) and fluid restrictions (49.5%). The prevalence of noncompliance with medication and fluid regimens was consistent with previous studies of dialysis patients but the prevalence of noncompliance with diet was much lower than that reported elsewhere. Prevalence of noncompliant patients varied between studies according to the cut-point used to establish compliance criteria, where more stringent cut-points inflated the percentage and more lenient cut-points reduced the percentage. Thus, there is a need to establish uniform criteria in order to test real differences in compliance between patient groups vs simply differences in measurement.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8235736     DOI: 10.1016/0277-9536(93)90438-a

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  27 in total

1.  Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality.

Authors:  Jennifer E Flythe; Stephen E Kimmel; Steven M Brunelli
Journal:  Kidney Int       Date:  2010-10-06       Impact factor: 10.612

2.  Depressive symptoms and dietary adherence in patients with end-stage renal disease.

Authors:  Amani A Khalil; Susan K Frazier; Terry A Lennie; B Peter Sawaya
Journal:  J Ren Care       Date:  2011-03

3.  Use of a token economy to increase compliance during hemodialysis.

Authors:  J S Carton; J B Schweitzer
Journal:  J Appl Behav Anal       Date:  1996

4.  Relationship between illness perceptions, treatment adherence, and clinical outcomes in patients on maintenance hemodialysis.

Authors:  Youngmee Kim; Lorraine S Evangelista
Journal:  Nephrol Nurs J       Date:  2010 May-Jun       Impact factor: 0.959

5.  Impact of prescription benefit coverage limits on sevelamer hydrochloride adherence for patients with ESRD.

Authors:  Bharati Bhardwaja; Nikki Carroll; Eli Korner; Kavita V Nair
Journal:  Am Health Drug Benefits       Date:  2009-09

6.  Emotion sharing in remote patient monitoring of patients with chronic kidney disease.

Authors:  Robin Huang; Na Liu; Mary Ann Nicdao; Mary Mikaheal; Tanya Baldacchino; Annabelle Albeos; Kathy Petoumenos; Kamal Sud; Jinman Kim
Journal:  J Am Med Inform Assoc       Date:  2020-02-01       Impact factor: 4.497

7.  Patient-stated preferences regarding volume-related risk mitigation strategies for hemodialysis.

Authors:  Jennifer E Flythe; Thomas W Mangione; Steven M Brunelli; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

8.  The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ): testing the psychometric properties in patients receiving in-center hemodialysis.

Authors:  Youngmee Kim; Lorraine S Evangelista; Linda R Phillips; Carol Pavlish; Joel D Kopple
Journal:  Nephrol Nurs J       Date:  2010 Jul-Aug       Impact factor: 0.959

9.  Development and cultural adaptation of the Spanish version of the End Stage Renal Disease Adherence Questionnaire (SESRD-AQ).

Authors:  Youngmee Kim; Lorraine S Evangelista
Journal:  Nephrol Nurs J       Date:  2013 Nov-Dec       Impact factor: 0.959

10.  Managing serum phosphate in haemodialysis patients: time for an innovative approach?

Authors:  A Collinson; M McMullan; W Y Tse; H Sadler
Journal:  Eur J Clin Nutr       Date:  2014-01-15       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.